186 related articles for article (PubMed ID: 34949436)
41. SLN mapping in early-stage cervical cancer as a minimal-invasive triaging tool for multimodal treatment.
Papadia A; Morosi C; Wang J; Gasparri ML; Rau T; Ghezzi F; Mueller MD
Eur J Surg Oncol; 2019 Apr; 45(4):679-683. PubMed ID: 30732972
[TBL] [Abstract][Full Text] [Related]
42. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions.
Cibula D; McCluggage WG
Gynecol Oncol; 2019 Jan; 152(1):202-207. PubMed ID: 30318103
[TBL] [Abstract][Full Text] [Related]
43. Clinical feasibility and diagnostic accuracy of detecting micrometastatic lymph node disease in sentinel and non-sentinel lyph nodes in cervical cancer: outcomes and implications.
Sniadecki M; Sawicki S; Wojtylak S; Liro M; Wydra D
Ginekol Pol; 2014 Jan; 85(1):10-3. PubMed ID: 24505957
[TBL] [Abstract][Full Text] [Related]
44. Molecular Diagnosis for Nodal Metastasis in Endoscopically Managed Cervical Cancer: The Accuracy of the APTIMA Test to Detect High-risk Human Papillomavirus Messenger RNA in Sentinel Lymph Nodes.
Köhler C; Le X; Dogan NU; Pfiffer T; Schneider A; Marnitz S; Bertolini J; Favero G
J Minim Invasive Gynecol; 2016; 23(5):748-52. PubMed ID: 26976197
[TBL] [Abstract][Full Text] [Related]
45. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
Moo TA; Edelweiss M; Hajiyeva S; Stempel M; Raiss M; Zabor EC; Barrio A; Morrow M
Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy.
Demirci S; Ozsaran Z; Ozsaran A; Yavas F; Demircioglu B; Hanhan M; Dikmen Y; Aras AB
Eur J Gynaecol Oncol; 2012; 33(1):62-7. PubMed ID: 22439408
[TBL] [Abstract][Full Text] [Related]
47. Micrometastases in Sentinel Lymph Nodes Represent a Significant Negative Prognostic Factor in Early-Stage Cervical Cancer: A Single-Institutional Retrospective Cohort Study.
Kocian R; Slama J; Fischerova D; Germanova A; Burgetova A; Dusek L; Dundr P; Nemejcova K; Jarkovsky J; Sebestova S; Fruhauf F; Dostalek L; Ballaschova T; Cibula D
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486512
[TBL] [Abstract][Full Text] [Related]
48. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study.
Cabıoğlu N; Karanlık H; Yıldırım N; Müslümanoğlu M; Çakmak Karadeniz G; Trabulus Can D; Tükenmez M; Ersoy YE; Uras C; Zengel B; Emiroğlu S; Polat AK; Yeniay L; Özkurt E; Kara H; İbiş K; Aydıner A; Özmen V; İğci A
Eur J Surg Oncol; 2021 Oct; 47(10):2506-2514. PubMed ID: 34217580
[TBL] [Abstract][Full Text] [Related]
49. Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers.
Tvedskov TF; Jensen MB; Balslev E; Garne JP; Vejborg I; Christiansen P; Ejlertsen B; Kroman N
Acta Oncol; 2016; 55(4):455-9. PubMed ID: 26452696
[TBL] [Abstract][Full Text] [Related]
50. SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm.
Dostálek L; Zikan M; Fischerova D; Kocian R; Germanova A; Frühauf F; Dusek L; Slama J; Dundr P; Nemejcova K; Cibula D
Gynecol Oncol; 2018 Mar; 148(3):456-460. PubMed ID: 29366509
[TBL] [Abstract][Full Text] [Related]
51. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
52. Correlation between outcome and extent of residual disease in the sentinel node after neoadjuvant chemotherapy in clinically fine-needle proven node-positive breast cancer patients.
Canavese G; Tinterri C; Carli F; Garrone E; Spinaci S; Della Valle A; Barbieri E; Marrazzo E; Bruzzi P; Dozin B
Eur J Surg Oncol; 2021 Aug; 47(8):1920-1927. PubMed ID: 33972144
[TBL] [Abstract][Full Text] [Related]
53. The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
Kim JH; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
World J Surg Oncol; 2018 Mar; 16(1):52. PubMed ID: 29523141
[TBL] [Abstract][Full Text] [Related]
54. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
[TBL] [Abstract][Full Text] [Related]
55. MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
Nitecki R; Ramirez PT; Dundr P; Nemejcova K; Ribeiro R; Vieira Gomes MT; Schmidt RL; Bedoya L; Isla DO; Pareja R; Rendón Pereira GJ; Lopez A; Kushner D; Cibula D
Int J Gynecol Cancer; 2023 Nov; 33(11):1684-1689. PubMed ID: 37652529
[TBL] [Abstract][Full Text] [Related]
56. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging.
Balaya V; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngô C; Le Frère-Belda MA; Mathevet P; Lécuru F
Gynecol Oncol; 2020 Sep; 158(3):576-583. PubMed ID: 32595022
[TBL] [Abstract][Full Text] [Related]
57. Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma.
Fastrez M; Goffin F; Vergote I; Vandromme J; Petit P; Leunen K; Degueldre M
Acta Obstet Gynecol Scand; 2013 Aug; 92(8):895-901. PubMed ID: 23590725
[TBL] [Abstract][Full Text] [Related]
58. [Prevalence of micrometastases and isolated tumor cells in the sentinel node at early stage breast cancer].
Cordero García JM; Palomar Muñoz A; Delgado Portela M; García Vicente AM; Pilkington Woll JP; Poblete García VM; Bellón Guardia ME; Pardo García R; Rabadán Ruiz L; Soriano Castrejón A
Rev Esp Med Nucl Imagen Mol; 2012; 31(2):78-82. PubMed ID: 21658817
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
[TBL] [Abstract][Full Text] [Related]
60. Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A systematic review.
Liokatis P; Liokati I; Obermeier K; Smolka W; Ersan F; Dewenter I; Otto S; Philipp P; Siegmund B; Walz C; Braunschweig T; Klauschen F; Mock A
Oral Oncol; 2024 Jul; 154():106808. PubMed ID: 38823172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
